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Background:  Proteoglycans such as versican, as well as low-density lipoprotein (LDL) and oxidized LDL contain tryptophan, an amino acid 
with characteristic fluorescence at 308 nm excitation wavelength. We demonstrate that intrinsic fluorescence spectroscopy at 308 nm excitation 
(IFS308) can identify coronary lesions with superficial foam cells (SFCs) and/or proteoglycans.
Methods:  119 human coronary specimens were subjected to in vitro fluorescence and reflectance measurements. 5 basis spectra were used 
to model IFS308 (Figure 1). We extracted their contributions to each individual IFS308 spectrum. An algorithm using the contributions of total 
tryptophan and fibrous cap to IFS308 identified specimens with SFCs and/or proteoglycans in their top 50 μm.
Results:  We detected SFCs and/or proteoglycans, such as versican or the glycosaminoglycan hyaluronan, in 24 fibrous cap atheromas or 
pathologic intimal thickening (PIT) lesions. An algorithm using the contributions of total tryptophan and fibrous cap to IFS308 was able to identify 
these segments with 92% sensitivity and 80% specificity.
Conclusion: We established a set of characteristic LDL, oxidized LDL and versican fluorescence spectra. The IFS308 technique detects 
SFCs and/or proteoglycans in fibrous cap atheromas and PIT lesions. SFCs and proteoglycans are histological markers of vulnerable 
plaques, and our study could be a step further in developing an invasive clinical tool to detect the vulnerable atherosclerotic plaque. 
